Abstract
Telomerase beats gold standard biomarkers CA 19-9, CEA, and Mayo formula-differentiates cholangiocarcinoma from benign bile ducts ȁ It can be done with ERCP ȁ A major clinical diagnostic advancement
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
